(Source: bildbanken, Uppsala University. Photographer Martin Cejie)

Projects in the thematic research area of Alzheimers's disease:

Phase III (2013 - )

  • Aß and alpha-synuclein oligomers in CSF as diagnostic markers to follow disease progression and treatment effects.
  • New PET based diagnostics for imaging of disease progression and therapeutic effect of drug intervention for AD.
  • Mass spectrometry based identification of biomarkers and biomarker signatures for neuronal and synapse degeneration in AD.
  • Biobank collection and control.

Phase I & II (2007 - 2012)

  • Characterization of Aß and alpha-synuclein oligomers [read_more]
  • Biomarkers for synapse and neuronal degeneration [read more]



Uppsala Berzelii Technology Centre for Neurodiagnostics | Email info@berzelii.uu.se